We’re thrilled to share that our Cohort 8.0 founder Garland Surgical has been awarded a grant from the West Midlands Health Tech Innovation Accelerator (WMHTIA).
This significant funding represents a major milestone in their journey toward the commercialisation of MaltaHip, the innovative ultra-low wear hip replacement designed specifically for younger, active patients.
With the support of the WMHTIA, which is funded by the Department for Science, Innovation and Technology in partnership with Innovate UK and the West Midlands Combined Authority, Garland will be able to accelerate their product rapidly. This grant will enable them to advance the development of MaltaHip, bringing them closer to offering a one-surgery solution that can improve the quality of life for countless individuals.
12 Dec 2025 | Cohort Successes
Accelerate Cohort 4.0 founders JET Connectivity have been selected as one of 150 companies to join...
11 Dec 2025 | Cohort Successes
BetaDen Accelerare Intake 2.0 founders FARx have announced the launch of the second iteration of...
04 Dec 2025 | Cohort Successes
BetaDen Incubate Intake 3.0 founders GreenUp have launched their sustainability awareness app,...